Work

Sphingosine kinase 2 (SPHK2) inhibition as a therapeutic strategy for adrenocortical carcinoma (ACC)

Year: 2026

Type: conference-abstract

Source: Endocrine Abstracts

DOI: 10.1530/endoabs.117.oc2.4

Authors: Kanwal Asif, Barbara Altieri, James Pittaway, Chris Smith, Ruth Kwong, Constanze Hantel, Sandra Sigala, Alfredo Berruti, Silviu Sbiera, Martin Fassnacht, Leonardo Guasti, Lou Metherell, Rathi Prasad

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130601559

Cites:

Cited by:

Related to: